Skip to main content
Caplight Logo









Nextera AS

Nextera AS

Private
OsloEnterprise Softwarehttps://nextera.no/

Last Round

Grant

Nov 21, 2025

Total Funding Raised

$1.12M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Nextera AS is a biotechnology company that develops precision drug candidates for the treatment of cancer, autoimmune diseases, and chronic inflammation using its proprietary NextCore protein engineering platform.

Sector

Enterprise Software

Verticals

Vertical SaaS, E-commerce, Logistics Software

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Non-AI

Keywords

travel techbooking enginereservation systemdynamic packagingtour operator softwaretravel agency softwareInternet Booking EngineIBEB2B travel platformtravel APIairline softwareGDS integrationtravel back officevertical SaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nextera AS Comparables

Compare Nextera AS with similar companies based on industry and business-model similarity.

Nextera AS comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sriggle
80%
Moonstride
80%
Toogonet
79%

Nextera AS Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantNov 21, 2025

Key People

Founding team and executive leadership

Geir Åge Løset

CEO, CSO

Executive Team

Nextera AS Investors

Notable investors and investment history

Nextera AS investors
InvestorRounds
The Research Council of NorwayGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors increased 39% MoM.

  • Mar 1, 2026

    Monthly visitors increased 34% MoM.

Nextera AS Filings

Explore SEC and related filing metadata, where available.

Nextera AS filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Nextera AS's valuation, stock price, and market status.

Is Nextera AS a public or private company?

Nextera AS is a private company.

What is the current stock price of Nextera AS?

Nextera AS is a private company with no public stock price. Caplight tracks Nextera AS's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Nextera AS worth (valuation)?

Valuation information for Nextera AS is not publicly available.

Can I buy Nextera AS stock?

Nextera AS shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Nextera AS's last funding round?

Nextera AS's most recent funding round was Grant on November 21, 2025.

Who are the main investors in Nextera AS?

Key investors in Nextera AS include The Research Council of Norway.

Will Nextera AS IPO soon?

No public IPO plans have been announced for Nextera AS.

How can I track Nextera AS secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nextera AS's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersOslo
Employee Range13
Year Founded2009
Last FundingNov 21, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?